Oxcan
a UK-based medtech company that develops blood tests for early cancer detection using proteomics and AI
Oxford, UKwww.oxcan.org ↗
Total raised
€16M
€15,649,169
Funding rounds
3
Investors
16
distinct backers
Active since
2021-09
latest 2025-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood55
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-01-10 | Series A | €11M | Angel Investors,Aurelium Ventures,Civilization Ventures,Cross-Border Impact Ventures,DigitalDx Ventures,Eka Ventures+3 more | View deal → |
| 2023-01-10 | Other | €3.4M | Eka Ventures,LifeArc,MegaRobo Technologies,Oxford Technology Management | View deal → |
| 2021-09-06 | Seed | €1.5M | Cancer Research UK,Civilisation Ventures,Francis Crick Institute,MegaRobo,Oxford Technology Management | View deal → |